TY  - GEN
AU  - Keymeulen,B
AU  - Walter,M
AU  - Mathieu,C
AU  - Kaufman,L
AU  - Gorus,F
AU  - Hilbrands,R
AU  - Vandemeulebroucke,E
AU  - Van de Velde,U
AU  - Crenier,L
AU  - De Block,C
AU  - Candon,S
AU  - Waldmann,H
AU  - Ziegler,A G
AU  - Chatenoud,L
AU  - Pipeleers,D
TI  - Four-year metabolic outcome of a randomised controlled  CD3-antibody trial in recent-onset type 1 diabetic patients  depends on their age and baseline residual beta cell mass
SN  - 1432-0428
PY  - 2010///0423
KW  - Adult
KW  - Age Factors
KW  - Antibodies
KW  - therapeutic use
KW  - Belgium
KW  - CD3 Complex
KW  - immunology
KW  - Diabetes Mellitus, Type 1
KW  - drug therapy
KW  - Female
KW  - Follow-Up Studies
KW  - Glycated Hemoglobin
KW  - metabolism
KW  - Humans
KW  - Insulin-Secreting Cells
KW  - physiology
KW  - Lymphocyte Subsets
KW  - Male
KW  - Placebos
KW  - Registries
KW  - Time Factors
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00125-009-1644-9
ER  -